Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Martin M. Dokter"'
Autor:
Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Harmen G. Booij, Silke U. Oberdorf-Maass, Martin M. Dokter, Anouk H. G. Wolters, Ben N. G. Giepmans, Wiek H. van Gilst, Joan H. Brown, Rudolf A. de Boer, Herman H. W. Silljé, B. Daan Westenbrink
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract A Kinase Interacting Protein 1 (AKIP1) is a signalling adaptor that promotes physiological hypertrophy in vitro. The purpose of this study is to determine if AKIP1 promotes physiological cardiomyocyte hypertrophy in vivo. Therefore, adult ma
Externí odkaz:
https://doaj.org/article/ed562cee66ed427ca8cecb89312bca87
Autor:
Eerde H. Weening, Ali A. Al-Mubarak, Martin M. Dokter, Kenneth Dickstein, Chim C. Lang, Leong L. Ng, Marco Metra, Dirk J. van Veldhuisen, Daan J. Touw, Rudolf A. de Boer, Ron T. Gansevoort, Adriaan A. Voors, Stephan J. L. Bakker, Peter van der Meer, Nils Bomer
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Serum selenium levels have been associated with the incidence of heart failure (HF) and signs of the metabolic syndrome. In addition, notable differences have been reported between males and females in food intake and micronutrien
Externí odkaz:
https://doaj.org/article/0e391b3e786140c3859e2ca8f1016731
Autor:
Nils Bomer, John G.F. Cleland, Chim C. Lang, Martin M Dokter, Martijn F Hoes, Jan IJmker, Nilesh J. Samani, Stefan D. Anker, Dirk J. van Veldhuisen, Daan J Touw, Peter van der Meer, Leong L. Ng, Jasper Tromp, Koen W. Streng, Hans L. Hillege, Adriaan A. Voors, Mathilde C.S.C. Vermeer, Niels Grote Beverborg
Publikováno v:
European Journal of Heart Failure, 22(8), 1415-1423. Wiley
European Journal of Heart Failure
European Journal of Heart Failure
Aims:\ud Severe deficiency of the essential trace element selenium can cause myocardial dysfunction although the mechanism at cellular level is uncertain. Whether, in clinical practice, moderate selenium deficiency is associated with worse symptoms a
Autor:
Pieter Muntendam, Carolin Gehlken, Martin M Dokter, Wiek H. van Gilst, Wouter C. Meijers, Henk A. Schols, Rudolf A. de Boer, A. Rogier van der Velde, Herman H W Silljé
Publikováno v:
Current Research in Translational Medicine, 70(1):103321
Current Research in Translational Medicine 70 (2022) 1
Current Research in Translational Medicine, 70(1)
Current Research in Translational Medicine 70 (2022) 1
Current Research in Translational Medicine, 70(1)
Purpose of the study: A major challenge in cardiology remains in finding a therapy for cardiac fibrosis. Inhibition of galectin-3 with pectins attenuates fibrosis in animal models of heart failure. The purpose of this study is to identify pectins wit
Autor:
Tim R Eijgenraam, Cornelis J. Boogerd, Xiaoke Yin, Manuel Mayr, Lukas E Schmidt, Herman H W Silljé, Eva van Rooij, Peter van der Meer, Nienke M Stege, Martin M Dokter, Rudolf A. de Boer, Vivian Oliveira Nunes Teixeira, Jolanda van der Velden, Konstantinos Theofilatos
Publikováno v:
Circulation-Heart failure, 14(11):e008532. LIPPINCOTT WILLIAMS & WILKINS
Circulation. Heart failure, 14(11). Lippincott Williams and Wilkins Ltd.
Circulation. Heart failure, 14(11). Lippincott Williams and Wilkins
Circulation. Heart Failure
Eijgenraam, T R, Boogerd, C J, Stege, N M, Oliveira Nunes Teixeira, V, Dokter, M M, Schmidt, L E, Yin, X, Theofilatos, K, Mayr, M, van der Meer, P, van Rooij, E, van der Velden, J, Silljé, H H W & de Boer, R A 2021, ' Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy : Development of PLN-R14del-Related Cardiomyopathy ', Circulation. Heart failure, vol. 14, no. 11, pp. e008532 . https://doi.org/10.1161/CIRCHEARTFAILURE.121.008532
Circulation. Heart failure, 14(11). Lippincott Williams and Wilkins Ltd.
Circulation. Heart failure, 14(11). Lippincott Williams and Wilkins
Circulation. Heart Failure
Eijgenraam, T R, Boogerd, C J, Stege, N M, Oliveira Nunes Teixeira, V, Dokter, M M, Schmidt, L E, Yin, X, Theofilatos, K, Mayr, M, van der Meer, P, van Rooij, E, van der Velden, J, Silljé, H H W & de Boer, R A 2021, ' Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy : Development of PLN-R14del-Related Cardiomyopathy ', Circulation. Heart failure, vol. 14, no. 11, pp. e008532 . https://doi.org/10.1161/CIRCHEARTFAILURE.121.008532
Supplemental Digital Content is available in the text.
Background: The p.(Arg14del) pathogenic variant (R14del) of the PLN (phospholamban) gene is a prevalent cause of cardiomyopathy with heart failure. The exact underlying pathophysiology is un
Background: The p.(Arg14del) pathogenic variant (R14del) of the PLN (phospholamban) gene is a prevalent cause of cardiomyopathy with heart failure. The exact underlying pathophysiology is un
Autor:
Kirsten T Nijholt, Rudolf A. de Boer, Salva R. Yurista, Martin M Dokter, Dirk J. van Veldhuisen, Herman H W Silljé, B. Daan Westenbrink
Publikováno v:
Cardiovascular Drugs and Therapy, 35, 953-963. SPRINGER
Cardiovascular Drugs and Therapy
Cardiovasc Drugs Ther
Cardiovascular Drugs and Therapy
Cardiovasc Drugs Ther
Background Heart failure (HF) is considered to be a prothrombotic condition and it has been suggested that coagulation factors contribute to maladaptive cardiac remodelling via activation of the protease-activated receptor 1 (PAR1). We tested the hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90fbe69b4dbcf8929667a77dd3210491
https://research.rug.nl/en/publications/c7bac4b0-6f6d-447c-92ed-2d8ca568e9e3
https://research.rug.nl/en/publications/c7bac4b0-6f6d-447c-92ed-2d8ca568e9e3
Autor:
Cornelis J. Boogerd, Martin M Dokter, B. Daan Westenbrink, Herman H W Silljé, George Markousis-Mavrogenis, Rudolf A. de Boer, Laura M G Meems, Carolyn S.P. Lam, Elisabeth Maria Schouten, Coenraad Withaar, Adriaan A. Voors
Publikováno v:
Cardiovascular Research
Cardiovascular Research, 117(9), 2108-2124. Oxford University Press
Cardiovascular Research, 117(9), 2108-2124. Oxford University Press
AIMS: Heart failure with preserved ejection fraction (HFpEF) is a multifactorial disease that constitutes several distinct phenotypes, including a common cardiometabolic phenotype with obesity and type 2 diabetes mellitus. Treatment options for HFpEF
Autor:
R. A. De Boer, M. Metra, C. Shi, Martin M Dokter, H. H. Van Der Wal, J. Post, F. Zannad, Adriaan A. Voors, Chim C. Lang, F. van den Berg, John G.F. Cleland, P. L. van Haelst, Jourik A. Gietema, L. Huizinga, D. J. Van Veldhuisen, Kenneth Dickstein, Pietro Ameri, Nilesh J. Samani, Marco Canepa, Leong L. Ng, M. Vriesema, Herman H W Silljé, Stefan D. Anker
Publikováno v:
Journal of Internal Medicine
Journal of Internal Medicine, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
Journal of Internal Medicine, 288(2), 207-218. Wiley
Journal of Internal Medicine, Wiley, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
Journal of Internal Medicine, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
Journal of Internal Medicine, 288(2), 207-218. Wiley
Journal of Internal Medicine, Wiley, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
International audience; Background: There is increasing recognition that heart failure (HF) and cancer are conditions with a number of shared characteristics.Objectives: To explore the association between tumour biomarkers and HF outcomes.Methods: In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8f62717f9e72a22640ecd5cfe68797
http://hdl.handle.net/11567/1024218
http://hdl.handle.net/11567/1024218
Autor:
Marco Metra, Michiel Rienstra, Stefan D. Anker, Dirk J. van Veldhuisen, Pim van der Harst, Johanna E. Emmens, Carolyn S.P. Lam, Kenneth Dickstein, Faiez Zannad, Martin M Dokter, Nilesh J. Samani, Adriaan A. Voors, Chim C. Lang, Jasper Tromp, Jozine M. ter Maaten, Michelle Chan, Bernadet T. Santema, Haye H. van der Wal, Kevin Damman, Janny Takens, John G.F. Cleland, Leong L. Ng, Rudolf A. de Boer, Peter van der Meer
Publikováno v:
Clinical Research in Cardiology. 110:1351-1351
The original article can be found online.
Autor:
Michelle Chan, Carolyn S.P. Lam, Leong L. Ng, Kenneth Dickstein, Faiez Zannad, Johanna E. Emmens, Bernadet T. Santema, Michiel Rienstra, Adriaan A. Voors, Marco Metra, Rudolf A. de Boer, Chim C. Lang, Pim van der Harst, Jasper Tromp, Peter van der Meer, Janny Takens, Kevin Damman, John G.F. Cleland, Martin M Dokter, Jozine M. ter Maaten, Haye H. van der Wal, Stefan D. Anker, Dirk J. van Veldhuisen, Nilesh J. Samani
Publikováno v:
Clinical Research in Cardiology
Clinical Research in Cardiology, Springer Verlag, 2020, 109 (3), pp.331-338. ⟨10.1007/s00392-019-01513-y⟩
Clinical Research in Cardiology, 109(3), 331-338. SPRINGER HEIDELBERG
Clinical Research in Cardiology, Springer Verlag, 2020, 109 (3), pp.331-338. ⟨10.1007/s00392-019-01513-y⟩
Clinical Research in Cardiology, 109(3), 331-338. SPRINGER HEIDELBERG
Background In heart failure (HF), levels of NT-proBNP are influenced by the presence of concomitant atrial fibrillation (AF), making it difficult to distinguish between HF versus AF in patients with raised NT-proBNP. It is unknown whether levels of G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20d4b6fbdf0c79feeb7624b2c2be01d
http://hdl.handle.net/11379/517496
http://hdl.handle.net/11379/517496